Bone fragility is a hallmark of PLAO that frequently manifests as vertebral or other fragility fractures in late pregnancy or the postpartum period. Maternal health, quality of life, and functional independence are all significantly impacted by this disorder. Little is known about the risk factors for PLAO. Thus, this study was set to determine the risk factors for PLAO, both pregnancy-related and unrelated.
For this study, 182 women without PLAO and 155 women with PLAO were given a questionnaire about their pregnancy-related characteristics, lifestyle factors, nutritional practices, and clinical history.
In comparison to women without PLAO (31.6 ± 5.4 years, 13.8%, 5.5%, 2.2%, 2.6%, 50.8%, 6.0%, 0.5%, 11.0%, p<0.05 for all comparisons), women with PLAO were older (32.9 ± 4.7 years), had a higher prevalence of BMI <18.5 Kg/m2 (23.6%), eating disorders (11.6%), amenorrhea (7.1%), chronic diseases associated with bone fragility (11.7%), calcium intake <500 mg/day (66.9%), blue sclerae (5.2%), and had a family history of vertebral/femoral FXs (21.0%).
Pregnancy fragility fractures (odds ratio, OR 2.7, 95% Confidence Interval, CI, 1.199-6.036, p=0.016), chronic diseases (OR 5.8 95% CI, 1.919-17.562, p=0.002), age at pregnancy (OR 1.1, 95% CI, 1.005-1.109, p=0.030), BMI<18.5 Kg/m2 (OR 2.0, 95% CI, 1.042-3.902, p=0.037), and calcium intake <500 mg/day (OR 2.5 95% CI, 1.485-4.166, p=0.01) were all linked to the risk of PLAO.
PLAO women were more likely to have a history of bed rest (21.9%), usage of low-molecular-weight heparin (LMWH, 25.2%), calcium consumption <500 mg/day (67.1%), and inadequate weight growth (49.0%) during pregnancy.
LMWH usage (OR 2.0, 95% CI, 1.124-3.682, p=0.019), inadequate weight growth (OR 1.8, 95% CI, 1.109-3.003 p=0.018), and calcium consumption <500 mg/day during pregnancy (OR 1.5, 95% CI, 1.047-2.141, p=0.027) were linked to an elevated risk of PLAO. Overall, the characteristics that may be evaluated prior to pregnancy and linked to PLAO include underweight, inadequate calcium consumption, age at pregnancy initiation, prior fragility fractures, and the presence of chronic conditions.
Source:
Grassi, G., Zampogna, M., Atlasova, A., Rondinella, S., Ghielmetti, A., Siracusano, G., Chiodini, I., Mantovani, G., & Eller-Vainicher, C. (2025). Identifying risk factors for pregnancy and lactation-associated osteoporosis: insights from an Italian survey in PLAO patients and controls. Frontiers in Endocrinology, 16(1612188). https://doi.org/10.3389/fendo.2025.1612188
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.